Tran T H C, Bodaghi B, Rozenberg F, Cassoux N, Fardeau C, LeHoang P
Service d'Ophtalmologie, Hôpital Pitié Salpêtière, 47-83, boulevard de l'Hôpital, 75013 Paris.
J Fr Ophtalmol. 2004 Mar;27(3):223-36. doi: 10.1016/s0181-5512(04)96124-4.
To study the viral cause and present the management of necrotizing herpetic retinopathies.
Charts of patients presenting with acute retinal necrosis (ARN) or progressive outer retinal necrosis (PORN) diagnosed between March 1997 and June 2001 were retrospectively reviewed. Intraocular specimens were obtained in 33 cases to determine the viral cause using polymerase chain reaction-based assays and/or detection of intraocular antibody production.
The mean age was 43.4 Years. Herpesvirus genome was identified in 29 patients (80.5%). In the ARN group (32 patients, 38 eyes), herpes simplex virus (HSV) DNA was found in 11 patients (34.4%), varicella-zoster virus (VZV) in nine patients (28.1%), and cytomegalovirus (CMV) in four patients (12.5%). One patient (3.1%) presented an Epstein-Barr virus (EBV) infection. ARN was bilateral at initial examination in six patients and secondary bilateralization was observed in four patients. In the PORN group (four patients, eight eyes), the retinitis was bilateral and VZV DNA was detected in all cases. Two patients were treated with intravenous acyclovir, six with foscarnet alone, ten with intravenous foscarnet + acyclovir, 18 with intravenous foscarnet and intravitreous ganciclovir injections. Complications of necrotizing herpetic retinitis were cataract (26%), optic nerve atrophy (23.9%), and retinal detachment (17.4%). Final visual acuity was less or equal to 20/200 in 47.8% of cases.
It is important to determine the specific viral etiology since progression and prognosis may be different in herpetic necrotizing retinitis caused by HSV, VZV, or CMV. Visual prognosis is improved by intensive antiviral therapy, but remains poor if complications occur.
研究坏死性疱疹性视网膜病变的病毒病因并介绍其治疗方法。
回顾性分析1997年3月至2001年6月间诊断为急性视网膜坏死(ARN)或进行性外层视网膜坏死(PORN)的患者病历。33例患者获取了眼内标本,采用基于聚合酶链反应的检测方法和/或检测眼内抗体产生来确定病毒病因。
平均年龄为43.4岁。29例患者(80.5%)检测到疱疹病毒基因组。在ARN组(32例患者,38只眼)中,11例患者(34.4%)发现单纯疱疹病毒(HSV)DNA,9例患者(28.1%)发现水痘 - 带状疱疹病毒(VZV),4例患者(12.5%)发现巨细胞病毒(CMV)。1例患者(3.1%)出现爱泼斯坦 - 巴尔病毒(EBV)感染。6例患者初诊时ARN为双侧性,4例患者出现继发性双侧病变。在PORN组(4例患者,8只眼)中,视网膜病变均为双侧性,所有病例均检测到VZV DNA。2例患者接受静脉注射阿昔洛韦治疗,6例仅接受膦甲酸钠治疗,10例接受静脉注射膦甲酸钠 + 阿昔洛韦治疗,18例接受静脉注射膦甲酸钠和玻璃体内注射更昔洛韦治疗。坏死性疱疹性视网膜病变的并发症包括白内障(26%)、视神经萎缩(23.9%)和视网膜脱离(17.4%)。47.8%的病例最终视力小于或等于20/200。
确定特定的病毒病因很重要,因为由HSV、VZV或CMV引起的疱疹性坏死性视网膜病变的进展和预后可能不同。强化抗病毒治疗可改善视力预后,但如果出现并发症则预后仍然较差。